Durlaza | Acetylsalicylic Acid Capsule, Extended Release Breastfeeding

Durlaza | Acetylsalicylic Acid Capsule, Extended Release while Breastfeeding

Q: My health care provider has asked me to use Durlaza | Acetylsalicylic Acid Capsule, Extended Release , what to do?

Durlaza | Acetylsalicylic Acid Capsule, Extended Release comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.

Q: If I am using Durlaza | Acetylsalicylic Acid Capsule, Extended Release , will my baby need extra monitoring?

Not much monitoring required while using Durlaza | Acetylsalicylic Acid Capsule, Extended Release

Nutrients from the food that you eat passes to your breast milk. Its good idea to take healthy diet while breastfeeding. You may need to consume more calories per day to support healthy body system. Some time it gets necessary take medicine while you are breastfeeding and as other food items passes into breast milk, medicine passes as well hence it becomes obvious to understand its effects while breastfeeding. We have analyzed many medications and in this sheet we will present some fact and known information associated with Durlaza | Acetylsalicylic Acid Capsule, Extended Release while breast-feeding.

What is Durlaza | Acetylsalicylic Acid Capsule, Extended Release used for?

DURLAZA is indicated to: Reduce the risk of death and myocardial infarction (MI) in patients with chronic coronary artery disease, such as patients with a history of MI or unstable angina pectoris or with chronic stable angina Reduce the risk of death and recurrent stroke in patients who have had an ischemic stroke or transient ischemic attack Limitation of Use: Use immediate-release aspirin, not DURLAZA in situations where a rapid onset of action is required (such as acute treatment of myocardial infarction or before percutaneous coronary intervention). DURLAZA is a nonsteroidal anti-inflammatory drug indicated to reduce the risk of death and myocardial infarction (MI) in patients with chronic coronary artery disease, such as patients with a history of MI or unstable angina pectoris or with chronic stable angina and to reduce the risk of death and recurrent stroke in patients who have had an ischemic stroke or transient ischemic attack (1) Limitation of Use : Use immediate-release aspirin, not DURLAZA in situations where a rapid onset of action is required (such as acute treatment of myocardial infarction or before percutaneous coronary intervention). (1, 4)

Is Durlaza | Acetylsalicylic Acid Capsule, Extended Release safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Durlaza | Acetylsalicylic Acid Capsule, Extended Release low risk for breastfeeding

Durlaza | Acetylsalicylic Acid Capsule, Extended Release contains only one active ingredient that is Aspirin. We have analyzed the usage of Aspirin in breastfeeding and our analysis suggest that Aspirin poses Low risk for infant while breastfeeding and hence Durlaza | Acetylsalicylic Acid Capsule, Extended Release itself shall be considered Low risk item for breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Because of the potential for serious adverse reactions in nursing infants from DURLAZA, choose either to discontinue DURLAZA or discontinue nursing.

Durlaza | Acetylsalicylic Acid Capsule, Extended Release Breastfeeding Analsys

Aspirin while Breastfeeding

Low Risk

CAS Number: 50-78-2

Excreted in non-significant amount into breast milk. Reye’s Syndrome has never been reported due to ASA through breast milk. It is thought to be highly unlikely to occur after isolated or small doses like those used for treatment of thrombosis or anti-abortion therapy. At high maternal dose, one case (dubious) of salicylic intoxication in the neonatal period and another case of thrombocytopenia in an infant have been reported. Likelihood of hemolysis should be considered in those patients with G6PD-deficiency. WHO Model List of Essential Medication: compatible while breastfeeding when used occasionally or small dose for antithrombotic prophylaxis management.

Durlaza | Acetylsalicylic Acid Capsule, Extended Release Breastfeeding Analsys - 2

Aspirin while Breastfeeding

CAS Number: 50-78-2

After aspirin ingestion, salicylic acid is excreted into breastmilk, with higher doses resulting in disproportionately higher milk levels. Long-term, high-dose maternal aspirin ingestion probably caused metabolic acidosis in one breastfed infant. Reye's syndrome is associated with aspirin administration to infants with viral infections, but the risk of Reye's syndrome from salicylate in breastmilk is unknown. An alternate drug is preferred over continuous high-dose, aspirin therapy. After daily low-dose aspiring (75 to 325 mg daily), no aspirin is excreted into breastmilk and salicylate levels are low. Daily low-dose aspirin therapy may be considered as an antiplatelet drug for use in breastfeeding women.[1][2][3].

Is Durlaza | Acetylsalicylic Acid Capsule, Extended Release safe while breastfeeding

I am nursing mother and I have already used Durlaza | Acetylsalicylic Acid Capsule, Extended Release, what should I do?

Durlaza | Acetylsalicylic Acid Capsule, Extended Release is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Durlaza | Acetylsalicylic Acid Capsule, Extended Release so you should inform him based on your convenience.

My health care provider has asked me to use Durlaza | Acetylsalicylic Acid Capsule, Extended Release, what to do?

Durlaza | Acetylsalicylic Acid Capsule, Extended Release comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.

If I am using Durlaza | Acetylsalicylic Acid Capsule, Extended Release, will my baby need extra monitoring?

Not much monitoring required while using Durlaza | Acetylsalicylic Acid Capsule, Extended Release

Who can I talk to if I have questions about usage of Durlaza | Acetylsalicylic Acid Capsule, Extended Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week